{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-030144","form_type":"8-K","ticker":"HOWL","cik":"0001785530","company_name":"Werewolf Therapeutics, Inc.","filed_at":"2024-02-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.526230+00:00","generated_at":"2026-06-06T04:56:27.311083+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Werewolf Therapeutics files prospectus supplement for up to $25M ATM offering","bullets":["Prospectus supplement filed to sell up to $25M of common stock via Leerink Partners.","Prior $50M ATM program fully exhausted, generating ~$50M in gross proceeds.","Shares outstanding as of Jan 31, 2024: 40,660,732.","Legal opinion from Wilmer Cutler Pickering Hale and Dorr attached as Exhibit 5.1.","Supplement under existing shelf registration (File 333-264844) declared effective May 20, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-030144","json":"https://secwatch.observer/filing/0001193125-24-030144.json","markdown":"https://secwatch.observer/filing/0001193125-24-030144.md","text":"https://secwatch.observer/filing/0001193125-24-030144.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1785530/000119312524030144/0001193125-24-030144-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1785530/000119312524030144/d772199d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T04:56:27.311083+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}